| Financial Year |
March 31 2020 |
| Monetary Funds |
47,597,153.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
140,032,443.73 |
| Advances to Suppliers |
10,621,651.55 |
| Other Receivables |
76,362,487.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
84,968,140.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,089,253.38 |
| Total Current Assets |
366,671,131.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,619,163.01 |
| Investment Properties |
-- |
| Fixed Assetes |
558,189,488.40 |
| Under-construction Projects |
33,374,365.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
5,173,081.13 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
141,044,190.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
372,825.78 |
| Sub-Total of Non-Current Assets |
741,585,614.56 |
| Total Assets |
1,108,256,745.73 |
| Short-Term Loans |
939,957,354.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
101,491,190.73 |
| Accounts Received In Advance |
3,659,640.19 |
| Employee Compensation Payable |
37,307,200.13 |
| Taxes Payable |
18,230,391.28 |
| Interest Payable |
1,023,203,578.23 |
| Dividend Payable |
-- |
| Other payables |
2,223,651,318.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,770,119,566.77 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
5,094,416,662.13 |
| Long-term Loans |
49,055,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
39,693,465.00 |
| Deferred Income Tax Liabilities |
2,676,827.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
158,948,740.42 |
| Total Liabilities |
5,253,365,402.55 |
| Paid-In Capital(Or Share Stock) |
599,561,402.00 |
| Capital Surplus |
1,842,170,298.10 |
| Surplus Reserve |
72,555,048.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,679,563,215.82 |
| Minority Stockholder's Interest |
1,386,044.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-4,146,494,701.25 |
| Owner's Equity（Stockholder's Equity） |
-4,145,108,656.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,108,256,745.73 |
